NanoXplore Inc. to Host Second Quarter 2023 Results Webcast on February 15, 2023

NanoXplore Inc. (" NanoXplore " or the " Company ") (TSX: GRA and OTCQX: NNXPF) is pleased to hold a webcast to discuss the results of its second quarter ended December 31, 2022, on Wednesday, February 15, 2023, at 8:30 a.m. (Eastern Time). The financial results will be released on Tuesday February 14, 2023, after market close.

Details of the Q2 Webcast

When : February 15, 2023, at 8:30 a.m. (Eastern Time)

Webcast : To listen to the live webcast, please join and register at:

https://edge.media-server.com/mmc/p/nke9vt6o

or via our website under Events and Presentations in our Investors section at https://nanoxplore.ca/events-presentations/

A replay of the webcast will be available through the link above or in the Investors section under Events and Presentations of the Company's website at www.nanoxplore.ca .

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities across North America and Europe. Please visit www.nanoxplore.ca .

For further information, please contact:

Martin Gagné
Director, Investor Relations
martin.gagne@nanoxplore.ca
Tel: 1 438.476.1927


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...
G6 Materials

G6 Materials

OverviewG6 Materials Corp. (TSXV:GGG,OTCQB:GPHBF) provides high-tech graphene solutions for a variety of commercial, research and military applications at low costs. Through the company’s wholly-owned subsidiary, Graphene Laboratories Inc., G6 Materials currently offers over 100 graphene and... Keep Reading...
G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp Closes $1,001,000 Private Placement

G6 Materials Corp. (TSXV:GGG) (OTC:GPHBF) (the “Company” or “G6”) is pleased to announce that it has closed a non-brokered private placement and issued 14,300,001 units at a price of $0.07 per unit to raise aggregate proceeds of $1,001,000.07. Each unit consists of one common share and one... Keep Reading...
G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. Announces Upsize of Private Placement to Raise $1,001,000

G6 Materials Corp. (the “Company” or “G6”) (TSXV:GGG) (OTC:GPHBF) is pleased to announce its intention to increase the size of its previously announced non-brokered private placement from C$350,000 to $1,001,000. The Company will issue up to 14,300,000 Units for total gross proceeds of up to... Keep Reading...
G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. Develops Disinfection Products to Fight the Spread of COVID-19

G6 Materials Corp. (the “Company” or “G6”) (TSXV:GGG) (OTC:GPHBF) is pleased to provide an update from its Research & Development department. The outbreak of the COVID-19 has drastically altered the economic landscape, and G6 management is optimizing the business model to accommodate the new... Keep Reading...

Interactive Chart

Latest Press Releases

Related News